AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair
Investigational New Drugs Sep 16, 2017
Moyal L, et al. - The intent here was to illustrate the mechanism underlying the effect of AN-7 on Dox-induced double-strand DNA breaks (DSBs) in cutaneous T-cell lymphoma (CTCL), MyLa and Hut78 cell lines. It was reported that AN-7 sensitized the CTCL cell lines to Dox, and when combined with Dox. It also sustained unrepaired DSBs by suppressing repair protein expression. A mechanistic rationale was yielded for combining AN-7 with Dox or other DSB inducers as a therapeutic modality in CTCL.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries